Patient characteristics | Baseline mean | 18-month mean |
---|---|---|
Age | 67 (11) | |
Women | 60 (58%) | |
White | 76 (74%) | |
HTN medication | 46 (45%) | 48 (47%) |
Glaucoma medication | ||
Trusopt | 20 (19%) | 18 (17%) |
Prostaglandin | 66 (64%) | 68 (66%) |
Brimonidine | 18 (17%) | 20 (19%) |
Timolol | 35 (34%) | 33 (32%) |
CCT | 541 (35) | 543 (36) |
IOP | 16.2 (4.2) | 14.4 (4.2) |
OPP | 51 (10) | 52 (8) |
SBP | 136 (20) | 133 (18) |
DBP | 84 (12) | 83 (10) |
MD | −3.1 (3.5) | −3.4 (3.7) |
PSD | 4 (3.5) | 4.3 (3.4) |
The numbers in parentheses represent either SD or percentage of total study group; age, sex and race were identical at 18-month follow-up.
CCT, central corneal thickness; DBP, diastolic blood pressure; HTN, hypertension; IOP, intraocular pressure; MD, mean deviation; OPP, ocular perfusion pressure; PSD, pattern SD; SBP, systolic blood pressure.